|
Immunohistochemical detection of Eag1 in tumours |
||||
| Tumour type |
Whole antibody |
Recombinant PhoA scFv |
||
|
|
||||
| N |
Positive |
N |
Positive |
|
|
|
||||
| Oesophagus carcinoma |
8 |
8 |
12 |
8 |
| Gastric carcinoma |
10 |
9 |
14 |
6 |
| Colon carcinoma |
8 |
6 |
40 |
31 |
| Hepatocellular carcinoma |
10 |
10 |
8 |
5 |
| Gallbladder carcinoma |
5 |
4 |
1 |
1 |
| Pancreatic carcinoma |
8 |
6 |
1 |
1 |
| Renal cell carcinoma |
9 |
9 |
9 |
6 |
| Transitional cell carcinoma |
9 |
8 |
6 |
4 |
| Prostate carcinoma |
56 |
55 |
1 |
1 |
| Cervical carcinoma |
9 |
7 |
- |
|
| Endometrial carcinoma |
10 |
10 |
- |
|
| Cystadenocarcinoma of the ovary |
10 |
10 |
- |
|
| Breast carcinoma |
230 |
196 |
116 |
95 |
| Bronchus carcinoma |
10 |
9 |
73 |
41 |
| Thyroid papillary carcinoma |
9 |
9 |
3 |
2 |
| Basalioma, spinalioma |
10 |
1 |
- |
|
| Malignant melanoma |
59 |
22 |
1 |
1 |
| Total |
470 |
378 (80%) |
286 |
202 (71%) |
Hemmerlein et al. Molecular Cancer 2006 5:41 doi:10.1186/1476-4598-5-41 |
||||